Symposium on Imaging Hallmarks of Cancer
Course information
Learning objectives
Course flyer
Programme Thursday, October 18
Friday, October 19
The Symposium is designed for scientists, radiologists, nuclear medicine physicians and other experts in cancer imaging interested in acquiring knowledge and sharing their expertise on cutting edge-methods to diagnose and manage cancer patients. An experienced multidisciplinary faculty will provide the delegates with a blend of novel experimental and clinical imaging methods used to diagnose cancer and improve cancer screening as well to interrogate cancer biology and physiology.
Learning objectives
- to learn how to use novel imaging methods to interrogate cancer biology and physiology
- to envision how translational research may help developing imaging research
- to become familiar with and understand the added value of image-guided intervention in cancer care
Course flyer
Programme Thursday, October 18
| 17:00-17:30 | Registration |
| 17:30-17:50 | Welcome and introduction L. Beleza, Lisbon/PT President of the Champalimaud Foundation ESOR Representative C. Matos, Lisbon/PT Host organiser |
| 18:00-18:30 | Keynote lecture Chair: C. Matos, Lisbon/PT Changes in the evaluation of medical tests: from results to consequences P. Bossuyt, Amsterdam/NL |
| 18:30-19:00 |
Interlude Imaging marine animals D. Parraga, Valencia/ES |
Friday, October 19
| 09:00-10:30 |
Pre clinical MR imaging Chair: C. Matos, Lisbon/PT New strategies for probing malignancy and pre-metastatic niches at ultra-high field N. Shemesh, Lisbon/PT Mapping pre-metastatic niches using advanced DW MRI at ultra-high field R. Simoes, Lisbon/PT Mapping N-stages in colorectal cancer using multiexponential T2* I. Santiago, Lisbon/PT Mapping the pancreas in-vivo using spatially encoded MRI S. Gonçalves, Lisbon/PT |
| 10:30-11:00 | Coffee break |
| 11:00-12:30 |
Radiomics Chair: N. Papanikolaou, Lisbon/PT Radiomics: what the radiologist needs to know L. Fournier, Paris/FR Radiomics: biological correclation and clinical challenges E. Sala, Cambridge/UK Building an imaging biobank in the era of radiomics E. Neri, Pisa/IT |
| 12:30-13:30 |
Lunch break |
| 13:30-15:00 | Imaging strategies for improving cancer screening Chair: V. Vilgrain, Clichy/FR Breast cancer T. Helbich, Vienna/AT Lung cancer H.-U. Kauczor, Heidelberg/DE Colon cancer A. Laghi, Latina/IT Prostate cancer J. Futterer, Nijmegen/NL |
| 15:00-15:30 |
Coffee break |
| 15:30-17:00 |
Whole body MRI in clinical oncology: where are we now? Chair: F. Caseiro Alves, Coimbra/PT Metastatic bone disease F. Lecouvet, Brussels/BE Multiple myeloma S. Punwani, London/UK Lymphoma M. Mayerhöfer, Vienna/AT |
| 17:00-18:00 |
Oncologic imaging: future perspectives Chair: L. Marti-Bonmati, Valencia/ES MR elastography to investigate cancer cell proliferation and metastases R. Sinkus, London/UK Mass spectrometry imaging for clinical research and cancer surgery R. Heeren, Maastricht/NL |
